K990786

Substantially Equivalent

ACCUSIGN DOA 10, ACCUSIGN DOA 10 PANEL, ACUSIGN MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP, BIOSIGN DOA10, BIOSIGN MET/OPI/

Applicant: Princeton BioMeditech Corp.
Product code: LAG
Advisory panel: Clinical Toxicology
Date received: 1999-03-10
Decision date: 1999-03-26
Decision: Substantially Equivalent
Clearance type: Special
Location: Monmouth Junction, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.